The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

Dry age-related macular degeneration, which accounts for about 85 to 90% of cases, progresses slowly and is characterized by the accumulation of yellowish deposits called drusen in the macula.

They slowly lose central vision as the macula—a small but important area in the center of the retina—becomes thinner and accumulates tiny clumps of protein called drusen. There are effective ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

What is known is that a layer of cells at the back of the eye, called the retinal pigment epithelium (RPE), is central to the illness. A buildup within the RPE of fats and proteins, called drusen ...